Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001209191-22-014988

Options or other derivatives

  • General Counsel acquired 80,929 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Barnett Valerie General Counsel 2022-02-28 Grant or award · Stock Option (Right to Buy) +48,671 48,671 D
Barnett Valerie General Counsel 2022-02-28 Grant or award · Restricted Stock Units +32,258 32,258 D
Loading xslF345X03/doc4.xml…